Fernando Rivera
Marqués de Valdecilla University Hospital(ES)Instituto de Investigación Marqués de Valdecilla(ES)Spanish Head & Neck Cancer Cooperative Group(ES)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology, Gastric Cancer Management and Outcomes, Genetic factors in colorectal cancer, Cancer Genomics and Diagnostics
Most-Cited Works
- → Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer(2008)3,682 cited
- → Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study(2008)2,958 cited
- → Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer(2020)2,821 cited
- → Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer(2013)2,231 cited
- → Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study(2010)1,795 cited
- → Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer